Insulin lispro (Humalog) in the treatment of diabetes mellitus: overview of belgian clinical data from global studies.
Bex
M
M
Afdeling Endocrinologie, Gasthuisberg, K.U.L., Leuven, Belgium.
Buysschaert
M
M
De Leeuw
I
I
De Schepper
J
J
Fery
F
F
Hermans
M P
MP
Keymeulen
B
B
Lauvaux
J P
JP
Letiexhe
M
M
Mathieu
C
C
Nobels
F R
FR
Rottiers
R
R
Scheen
A
A
Schmitt
H
H
Van Crombrugge
P
P
Van Gaal
L
L
D000293:Adolescent; D000328:Adult; D001530:Belgium; D001786:Blood Glucose / Q000032:analysis; D015331:Cohort Studies; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061268:Insulin Lispro; D008297:Male; D008875:Middle Aged; D011788:Quality of Life
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro